These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35143800)

  • 1. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
    Tsui E; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Balamurugan S; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan J; Ebert CD; Kim E; Madow B; Porco TC; Acharya NR;
    Ophthalmology; 2022 Jun; 129(6):661-667. PubMed ID: 35143800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
    JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
    Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
    Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
    Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
    Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.
    ; Acharya NR; Vitale AT; Sugar EA; Holbrook JT; Burke AE; Thorne JE; Altaweel MM; Kempen JH; Jabs DA
    Ophthalmology; 2023 Sep; 130(9):914-923. PubMed ID: 37318415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.
    Tomkins-Netzer O; Lightman SL; Burke AE; Sugar EA; Lim LL; Jaffe GJ; Altaweel MM; Kempen JH; Holbrook JT; Jabs DA;
    Ophthalmology; 2021 May; 128(5):719-728. PubMed ID: 32918964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.
    Kong CL; Kelly NK; Sundararajan M; Rathinam SR; Gonzales JA; Thundikandy R; Vedhanayaki R; Kanakath A; Murugan B; Doan T; Goldstein D; Al-Dhibi HA; Acharya NR
    Ocul Immunol Inflamm; 2022 Jan; 30(1):198-202. PubMed ID: 32779952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
    Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
    Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
    Kelly NK; Chattopadhyay A; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Cugley D; Lim LL; Suhler EB; Al-Dhibi HA; Ebert CD; Berlinberg EJ; Porco TC; Acharya NR;
    Ophthalmology; 2021 Sep; 128(9):1337-1345. PubMed ID: 33675850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) Trial.
    Sura AA; Sun Y; Reddy AK; Rathinam SR; Gonzales JA; Thundikandy R; Vedhanayaki R; Kanakath A; Murugan B; Doan TA; Lim LL; Suhler EB; Al-Dhibi HA; Acharya NR;
    Ocul Immunol Inflamm; 2024 Aug; 32(6):955-960. PubMed ID: 36701644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy.
    Lehpamer B; Moshier E; Pahk P; Goldberg N; Ackert J; Godbold J; Jabs DA
    Am J Ophthalmol; 2014 May; 157(5):1048-55. PubMed ID: 24487049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial.
    Mackensen F; Jakob E; Springer C; Dobner BC; Wiehler U; Weimer P; Rohrschneider K; Fiehn C; Max R; Storch-Hagenlocher B; Becker MD
    Am J Ophthalmol; 2013 Sep; 156(3):478-486.e1. PubMed ID: 23786783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.
    Berasategui B; Fonollosa A; Artaraz J; Ruiz-Arruza I; Ríos J; Matas J; Llorenç V; Diaz-Valle D; Sastre-Ibañez M; Arriola-Villalobos P; Adan A
    BMC Ophthalmol; 2018 Jul; 18(1):179. PubMed ID: 30029623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edema.
    Allegri P; Murialdo U; Peri S; Carniglia R; Crivelli MG; Compiano S; Autuori S; Mastromarino A; Zurria M; Marrazzo G
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1463-70. PubMed ID: 24519421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive topical interferon therapy in uveitic macular edema.
    Kawali A; Sanjay S; Mohan A; Mahendradas P; Shroff S; Shetty R
    Indian J Ophthalmol; 2022 Aug; 70(8):2986-2989. PubMed ID: 35918958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
    Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
    Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE
    Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L; Christen W; Foster CS
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subretinal fluid in uveitic macular edema: effect on vision and response to therapy.
    Lehpamer B; Moshier E; Goldberg N; Ackert J; Godbold J; Jabs DA
    Am J Ophthalmol; 2013 Jan; 155(1):143-9. PubMed ID: 23022159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical interferon therapy in uveitic macular edema.
    Kawali A; Sanjay S; Mohan A; Mahendradas P; Shetty R
    Indian J Ophthalmol; 2022 Dec; 70(12):4357-4361. PubMed ID: 36453344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.